About ge healthcare – GE Healthcare Achilles User Manual

Page 8

BMD-0208-06.11-EN-US

To receive Lunar News online, please register for SmartMail.
Go to www.gehealthcare.com/company/smartmail.html
and register to automatically receive the newsletter.

GE and GE Monogram are trademarks of General
Electric Company. *Achilles is a trademark of General
Electric Company. **All third-party trademarks are the
property of their respective owner.

General Electric Company reserves the right to make
changes in specifications and features shown herein,
or discontinue the product described at any time
without notice or obligation. Contact your GE
representative for the most current information.

GE Medical Systems Ultrasound & Primary Care
Diagnostics, LLC, a General Electric company, doing
business as GE Healthcare

Lunar Product Division:
Americas

GE Healthcare Lunar
Global Headquarters
PO Box 7550
Madison, WI 53707-7550
T: +1-800-535-7339
F: +1-608-223-2482

Europe, Middle-East & Africa

GE Healthcare Lunar
Kouterveldstraat 20
B-1831 Diegem, Belgium
T: +32-2-7197217
F: +32-2-7197359
[email protected]

Asia & Pacific

GE Healthcare Lunar
3/F GE China Technology Park
No. 1 Hua Tuo Road
Shanghai 201203, China
T: +86-21-38777888 (Ext. 60128 or 60480)
F: +86-21-38777451

1. Krieg M-A, Barkmann R, Gonnelli S, et al. Quantitative Ultrasound in the Management of

Osteoporosis: The 2007 ISCD Official Positions. J Clin Densitom: Assessment of Skeletal Health.
2008;11(1):163-187.

2. Hans D, Dargent-Molina P, Schott AM, et al. Ultrasonographic heel measurements to predict

hip fracture in elderly women: the EPIDOS prospective study. Lancet. 1996;348(9026):511-514.

3. Glüer Claus C, Eastell R, Reid DM, et al. Association of Five Quantitative Ultrasound Devices

and Bone Densitometry With Osteoporotic Vertebral Fractures in a Population-Based Sample:
The OPUS Study. J Bone Miner Res. 2004;19(5):782-793.

4. Simon D, Boring III JR. Chap. 6: Sensitivity, Specificity, and Predictive Value. In: HK Walker, WD

Hall, JW Hurst, ed. Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd
edition. Boston: Butterworths; 1990.

5. Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Rossi S, Gennari C. Ultrasound parameters in

osteoporotic patients treated with salmon calcitonin: A longitudinal study. Osteoporos Int.
1996;6(4):303-307.

6. Giorgino R, Paparella AP, Lorusso D, Mancuso S. Effects of oral alendronate treatment and

discontinuance on ultrasound measurements of the heel in postmenopausal osteoporosis.
North American Menopausal Society, September 1996.

7. Gonnelli S, Cepollaro C, Montagnani A, et al. Heel ultrasonography in monitoring alendronate

therapy: a four-year longitudinal study. Osteoporos Int. 2002;13(5):415-421.

About GE Healthcare:

GE Healthcare provides transformational medical technologies and services
that are shaping a new age of patient care. Our broad expertise in medical
imaging and information technologies, medical diagnostics, patient monitoring
systems, drug discovery, biopharmaceutical manufacturing technologies,
performance improvement and performance solutions services help our
customers to deliver better care to more people around the world at a lower
cost. In addition, we partner with healthcare leaders, striving to leverage the
global policy change necessary to implement a successful shift to sustainable
healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our
journey as we continuously develop innovations focused on reducing costs,
increasing access and improving quality around the world. Headquartered in
the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE:
GE). Worldwide, GE Healthcare employees are committed to serving healthcare
professionals and their patients in more than 100 countries. For more
information about GE Healthcare, visit our website at www.gehealthcare.com.